Group 1 - The core viewpoint of the news is that Kaili Medical has seen a significant increase in its stock price, rising 5.11% to 29.01 CNY per share, with a total market capitalization of 12.553 billion CNY and a trading volume of 253 million CNY [1] - Kaili Medical has experienced a continuous stock price increase for three consecutive days, with a cumulative increase of 5.34% during this period [1] - The company specializes in the research, development, production, and sales of medical diagnostic and treatment equipment, with its main revenue sources being color ultrasound (58.07%) and endoscopes and related therapeutic instruments (40.90%) [1] Group 2 - According to data from the top ten holdings of funds, Zhonghai Fund has a significant position in Kaili Medical, with its Zhonghai Healthcare Theme Stock A fund reducing its holdings by 146,800 shares, now holding 1.0112 million shares, which represents 6.95% of the fund's net value [2] - The Zhonghai Healthcare Theme Stock A fund has achieved a year-to-date return of 5.11% and a one-year return of 6.38%, ranking 966 out of 5488 and 3994 out of 4192 in its category, respectively [2] - The fund manager, He Wenyin, has been in charge for 3 years and 328 days, with the best fund return during this period being 30.86% and the worst being -40.32% [3]
开立医疗股价涨5.11%,中海基金旗下1只基金重仓,持有101.12万股浮盈赚取142.58万元